The Role of MDM2 Amplification and Overexpression in Tumorigenesis

Jonathan D Oliner1, Anne Y Saiki2, Sean Caenepeel2

  • 1Jon Oliner Consulting, Garrett Park, Maryland 20896.

Insights

Mouse double minute 2 (MDM2) negatively regulates tumor suppressor p53. MDM2 amplification and promoter single-nucleotide polymorphisms (SNPs) are key mechanisms driving cancer by reducing p53 activity.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Mouse double minute 2 (MDM2) is a crucial negative regulator of the tumor suppressor p53.
  • MDM2 controls p53's transcriptional activity, protein stability, and nuclear localization.
  • Elevated MDM2 expression is observed in many cancers, leading to impaired p53 functions like apoptosis and cell-cycle arrest.

Purpose of the Study:

  • To provide an overview of MDM2 amplification and promoter single-nucleotide polymorphisms (SNPs) in human cancer.
  • To highlight the role of MDM2 amplification in sarcoma and the impact of SNPs (SNP309, SNP285) on MDM2 expression and cancer risk.

Main Methods:

  • Review of genetic amplification and promoter single-nucleotide polymorphisms (SNPs) in human cancer.
  • Analysis of large-scale genomic profiling datasets, including The Cancer Genome Atlas (TCGA).
  • Evaluation of MDM2 amplification and SNP inheritance across diverse cancer types.

Main Results:

  • MDM2 amplification is frequently observed in sarcoma.
  • Specific SNPs, such as SNP309 and SNP285, influence MDM2 expression levels.
  • These genetic alterations contribute to cancer development by disrupting p53 pathway.

Conclusions:

  • MDM2 amplification and specific promoter SNPs are significant mechanisms in human oncogenesis.
  • Understanding these genetic events is crucial for evaluating cancer risk and developing targeted therapies.
  • Genomic profiling data provides valuable insights into the role of MDM2 in various cancers.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.6K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.4K
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
8.0K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
6.1K